Polytranscriptomic risk score for Alzheimer Disease in a large diverse multi‐center brain bank study

dc.contributor.authorCieza, Basilio
dc.contributor.authorYang, Zikun
dc.contributor.authorReyes-Dumeyer, Dolly
dc.contributor.authorLee, Annie J.
dc.contributor.authorDugger, Brittany N.
dc.contributor.authorJin, Lee-Way
dc.contributor.authorMurray, Melissa E.
dc.contributor.authorDickson, Dennis W.
dc.contributor.authorPericak-Vance, Margaret A.
dc.contributor.authorVance, Jeffery M.
dc.contributor.authorForoud, Tatiana M.
dc.contributor.authorMayeux, Richard
dc.contributor.authorTosto, Giuseppe
dc.contributor.departmentNeurology, School of Medicine
dc.date.accessioned2025-02-24T16:09:36Z
dc.date.available2025-02-24T16:09:36Z
dc.date.issued2025-01-03
dc.description.abstractBackground: Alzheimer’s disease (AD) missing heritability remains extensive despite numerous genetic risk loci identified by genome‐wide association or sequencing studies. This has been attributed, at least partially, to mechanisms not currently investigated by traditional single‐marker/gene approaches. Polygenic Risk Scores (PRS) aggregate sparse genetic information across the genome to identify individual genetic risk profiles for disease prediction and patient risk stratification. Recent advancements have pivoted on innovative approaches utilizing OMICS data to construct such risk scores. Method: We employed a random forest algorithm to identify a list of gene candidates from bulk RNA sequencing data in prefrontal cortex from 565 AD brain samples (non‐Hispanic Whites, n = 399; Hispanics, n = 113; African American, n = 12) across six U.S. brain banks. Subsequently, we calculated their effect size on Braak staging using regression models to construct a polytranscriptomic risk score (PTRS). We employed two distinct models: “Ethnicity‐Agnostic” Model (randomly assigning samples to training and testing samples) and “Ethnicity‐Aware” Model (assigning NHW samples to training and Hispanics to testing sample). Analysis of variance and the receiver operating characteristics area under the curve (ROC AUC) was used to evaluate PTRS’s classification performances. We validated findings using the Religious Orders Study/Memory and Aging Project study (ROS/MAP, n = 1,095). Result: We found a significant difference in PTRS between samples with low vs. high Braak stages (≤4 vs. ≥5, p = 1*E‐04; Figure 1 upper panel). AUC was found to be 79‐81%, consistently in both Ethnicity‐Agnostic and Ethnicity‐Aware models (Figure 1 lower panel). Finally, the PTRS in ROS/MAP yielded a similar classification performance (p = 2*E‐04, AUC = 77%). Conclusion: Contrary to prior studies, we developed a PTRS with optimal transferability across ethnicities. This underscores the importance of developing novel tools to stratify and harmonize large brain repositories for AD.
dc.eprint.versionFinal published version
dc.identifier.citationCieza B, Yang Z, Reyes‐Dumeyer D, et al. Polytranscriptomic risk score for Alzheimer Disease in a large diverse multi‐center brain bank study. Alzheimers Dement. 2025;20(Suppl 1):e092971. Published 2025 Jan 3. doi:10.1002/alz.092971
dc.identifier.urihttps://hdl.handle.net/1805/45977
dc.language.isoen_US
dc.publisherWiley
dc.relation.isversionof10.1002/alz.092971
dc.relation.journalAlzheimer's & Dementia
dc.rightsAttribution 4.0 Internationalen
dc.rights.urihttps://creativecommons.org/licenses/by/4.0
dc.sourcePMC
dc.subjectAlzheimer’s disease (AD)
dc.subjectHeritability
dc.subjectGenetic risk loci
dc.subjectGenome‐wide association
dc.subjectSequencing studies
dc.subjectPolygenic Risk Scores (PRS)
dc.titlePolytranscriptomic risk score for Alzheimer Disease in a large diverse multi‐center brain bank study
dc.typeAbstract
Files
Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Cieza2025Polytranscriptomic-CCBY.pdf
Size:
242.01 KB
Format:
Adobe Portable Document Format
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
2.04 KB
Format:
Item-specific license agreed upon to submission
Description: